NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Medical Devices · USD

iRhythm Holdings, Inc. (IRTC) Stock Analysis

iRhythm Holdings, Inc. (IRTC) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

IRTC

$123.07

−$0.36 (−0.29%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare IRTC with… →

IRTC Key Statistics

As of Sep 4, 2026
Trading
Open
$121.47
Previous Close
$123.43
Day's Range
120.57–123.52
52-Week Range
100.85–212.00
Volume
444.50K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.32
Valuation
Market Cap
$4.06B
P/E Ratio
unprofitable
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
101.41
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
4.92
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.42
Financials (FY)
Revenue (FY)
$747.14M+26.24%
Net Income (FY)
−$44.55M
Profit marginThe share of revenue left as profit after all costs and taxes.
−1.69%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
32.96M
1-Year Return
−32.44%
Dividend and dates
Earnings Date
November 5, 2026
Avg Volume
598.30K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

IRTC Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−30.64%
2025+96.78%
2024−15.76%
2023+14.27%
2022−20.41%
2021−50.39%
2020+248.38%
2019−2.00%
2018+23.96%
2017+86.83%
2016 (partial year)+15.16%

As of September 4, 2026.

IRTC Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$747.14M−$44.55M−6.0%
2024$591.84M−$113.29M−19.1%
2023$492.68M−$123.41M−25.0%
2022$410.92M−$116.16M−28.3%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$747.14M$527.25M−$52.95M−$44.55M−6.0%
2024$591.84M$407.53M−$114.86M−$113.29M−19.1%
2023$492.68M$331.81M−$114.08M−$123.41M−25.0%
2022$410.92M$281.63M−$87.18M−$116.16M−28.3%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

IRTC Valuation vs Medical Devices Median

Median of 151 stocks
MetricIRTCMedical Devices medianvs median
P/S ratio4.922.9865% above
Profit margin−1.69%−1.69%0.0 pts above

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 15 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

iRhythm Holdings, Inc. (IRTC) carries a market capitalisation of $4.06B. It is classified in the Medical Devices industry, within the Healthcare sector. Headcount on file is 2,400.

IRTC last closed at $123.07 on September 4, 2026. That is −$0.36 (−0.29%) against the previous close. The 52-week range on file runs from $100.85 to $212.00. The latest close sits 22.04% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $747.14M. Against the prior fiscal year total of $591.84M, that is a change of +26.24%. The same year closed with a net loss of $44.55M. Profit margin runs at −1.69%. Earnings per share on a trailing basis come to −0.42.

Across the 4 fiscal years on file, revenue moves from $410.92M in 2022 to $747.14M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. The forward P/E on file is 101.41. Measured against sales, the shares trade at 4.92 times revenue. On price-to-sales that is 65.16% above the Medical Devices median of 2.98. The medians here are taken across 151 Medical Devices companies that report the metric.

The trailing one-year price return is −32.44%. Measured over 5 years, that is +21.05% a year compounded. Beta against the wider market is reported at 1.32. Daily returns over the trailing 9 years annualize to a volatility of 63.29%.

Growth & Income

No dividend is on file for IRTC.

2026 is still running; the price is −30.64% year to date. The strongest complete calendar year on file is 2020 at +248.38%; the weakest is 2021 at −50.39%. Of the 9 complete calendar years on file, 5 finished higher.

Peer Comparison

iRhythm Holdings, Inc. (IRTC) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
iRhythm Holdings, Inc. IRTC $4.06B —
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. iRhythm Holdings, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

 MDT

Medtronic plc.

$120.46B

 SYK

Stryker Corporation

$116.27B

 BSX

Boston Scientific Corporation

$69.27B

 EW

Edwards Lifesciences Corporation

$51.82B

 DXCM

DexCom, Inc.

$33.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About iRhythm Holdings, Inc.

iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data. In addition, the company offers Zio AT System, a prescription-only remote ECG monitoring system, which consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days, as well as incorporates the Zio AT wireless gateway to provide connectivity between the patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with BioIS to develop and commercialize pulse oximetry, accelerometry, and trending non-invasive blood pressure technologies for use within ambulatory cardiac monitoring products and services. The company was formerly known as iRhythm Technologies, Inc. and changed its name to iRhythm Holdings, Inc. in January 2026. iRhythm Holdings, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.

Visit website →